Literature DB >> 24132187

Coronary evaginations are associated with positive vessel remodelling and are nearly absent following implantation of newer-generation drug-eluting stents: an optical coherence tomography and intravascular ultrasound study.

Maria D Radu1, Lorenz Räber, Bindu Kalesan, Takashi Muramatsu, Henning Kelbæk, Jungho Heo, Erik Jørgensen, Steffen Helqvist, Vasim Farooq, Salvatore Brugaletta, Hector M Garcia-Garcia, Peter Jüni, Kari Saunamäki, Stephan Windecker, Patrick W Serruys.   

Abstract

OBJECTIVES: The purpose of this study was to assess the occurrence, predictors, and mechanisms of optical coherence tomography (OCT)-detected coronary evaginations following drug-eluting stent (DES) implantation.
BACKGROUND: Angiographic ectasias and aneurysms in stented segments have been associated with a risk of late stent thrombosis. Using OCT, some stented segments show coronary evaginations reminiscent of ectasias.
METHODS: Evaginations were defined as outward bulges in the luminal contour between struts. They were considered major evaginations (MEs) when extending ≥3 mm along the vessel length, with a depth ≥10% of the stent diameter. A total of 228 patients who had sirolimus (SES)-, paclitaxel-, biolimus-, everolimus (EES)-, or zotarolimus (ZES)-eluting stents implanted in 254 lesions, were analysed after 1, 2, or 5 years; and serial assessment using OCT and intravascular ultrasound (IVUS) was performed post-intervention and after 1 year in 42 patients.
RESULTS: Major evaginations occurred frequently at all time points in SES (∼26%) and were rarely seen in EES (3%) and ZES (2%, P = 0.003). Sirolimus-eluting stent implantation was the strongest independent predictor of ME [adjusted OR (95% CI) 9.1 (1.1-77.4), P = 0.008]. Malapposed and uncovered struts were more common in lesions with vs. without ME (77 vs. 25%, P < 0.001 and 95 vs. 20%, P < 0.001, respectively) as was thrombus [49 vs. 14%, OR 7.3 (95% CI: 1.7-31.2), P = 0.007]. Post-intervention intra-stent dissection and protrusion of the vessel wall into the lumen were associated with an increased risk of evagination at follow-up [OR (95% CI): 2.9 (1.8-4.9), P < 0.001 and 3.3 (1.6-6.9), P = 0.001, respectively]. In paired IVUS analyses, lesions with ME showed a larger increase in the external elastic membrane area (20% area change) compared with lesions without ME (5% area change, P < 0.001).
CONCLUSION: Optical coherence tomography-detected MEs are a specific morphological footprint of early-generation SES and are nearly absent in newer-generation ZES and EES. Evaginations appear to be related to vessel injury at baseline; are associated with positive vessel remodelling; and correlate with uncoverage, malapposition, and thrombus at follow-up.

Entities:  

Keywords:  Coronary evaginations; Early-generation drug-eluting stents; Intravascular ultrasound; Malapposition; Newer-generation drug-eluting stents; Optical coherence tomography; Positive remodelling; Uncovered stent struts

Mesh:

Substances:

Year:  2013        PMID: 24132187     DOI: 10.1093/eurheartj/eht344

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  11 in total

1.  Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.

Authors:  Lei Song; Gary S Mintz; Dong Yin; Myong Hwa Yamamoto; Chee Yang Chin; Mitsuaki Matsumura; Khady Fall; Ajay J Kirtane; Manish A Parikh; Jeffrey W Moses; Ziad A Ali; Richard A Shlofmitz; Akiko Maehara
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-09       Impact factor: 2.357

2.  Coronary stent thrombosis: what have we learned?

Authors:  Carlos Collet; Yohei Sotomi; Rafael Cavalcante; Pannipa Suwannasom; Erhan Tenekecioglu; Yoshinobu Onuma; Patrick W Serruys
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

3.  Comparison of neointimal coverage and extra-stent lumen between sirolimus and everolimus-eluting stent using optical coherence tomography.

Authors:  Takamasa Oda; Takayuki Okamura; Jutaro Yamada; Naoto Miyagi; Hiroki Uehara; Tomoko Nao; Hiroki Tateishi; Takao Maeda; Takeshi Nakamura; Kohzoh Shiraishi; Tadamitsu Nakashima; Shigehiko Nishimura; Toshiro Miura; Masunori Matsuzaki; Masafumi Yano
Journal:  Heart Vessels       Date:  2015-01-23       Impact factor: 2.037

4.  Incidence and natural history of coronary evagination after implanted biodegradable polymer sirolimus-eluting stent.

Authors:  Keiko Tsuji; Masaru Ishida; Tomonori Itoh; Takumi Kimura; Tatsuo Kikuchi; Munenori Okubo; Takatoshi Hayashi; Hiromasa Otake; Toshiro Shinke; Yoshihiro Morino
Journal:  Eur Heart J Open       Date:  2022-02-04

Review 5.  Optical coherence tomography in coronary atherosclerosis assessment and intervention.

Authors:  Makoto Araki; Seung-Jung Park; Harold L Dauerman; Shiro Uemura; Jung-Sun Kim; Carlo Di Mario; Thomas W Johnson; Giulio Guagliumi; Adnan Kastrati; Michael Joner; Niels Ramsing Holm; Fernando Alfonso; William Wijns; Tom Adriaenssens; Holger Nef; Gilles Rioufol; Nicolas Amabile; Geraud Souteyrand; Nicolas Meneveau; Edouard Gerbaud; Maksymilian P Opolski; Nieves Gonzalo; Guillermo J Tearney; Brett Bouma; Aaron D Aguirre; Gary S Mintz; Gregg W Stone; Christos V Bourantas; Lorenz Räber; Sebastiano Gili; Kyoichi Mizuno; Shigeki Kimura; Toshiro Shinke; Myeong-Ki Hong; Yangsoo Jang; Jin Man Cho; Bryan P Yan; Italo Porto; Giampaolo Niccoli; Rocco A Montone; Vikas Thondapu; Michail I Papafaklis; Lampros K Michalis; Harmony Reynolds; Jacqueline Saw; Peter Libby; Giora Weisz; Mario Iannaccone; Tommaso Gori; Konstantinos Toutouzas; Taishi Yonetsu; Yoshiyasu Minami; Masamichi Takano; O Christopher Raffel; Osamu Kurihara; Tsunenari Soeda; Tomoyo Sugiyama; Hyung Oh Kim; Tetsumin Lee; Takumi Higuma; Akihiro Nakajima; Erika Yamamoto; Krzysztof L Bryniarski; Luca Di Vito; Rocco Vergallo; Francesco Fracassi; Michele Russo; Lena M Seegers; Iris McNulty; Sangjoon Park; Marc Feldman; Javier Escaned; Francesco Prati; Eloisa Arbustini; Fausto J Pinto; Ron Waksman; Hector M Garcia-Garcia; Akiko Maehara; Ziad Ali; Aloke V Finn; Renu Virmani; Annapoorna S Kini; Joost Daemen; Teruyoshi Kume; Kiyoshi Hibi; Atsushi Tanaka; Takashi Akasaka; Takashi Kubo; Satoshi Yasuda; Kevin Croce; Juan F Granada; Amir Lerman; Abhiram Prasad; Evelyn Regar; Yoshihiko Saito; Mullasari Ajit Sankardas; Vijayakumar Subban; Neil J Weissman; Yundai Chen; Bo Yu; Stephen J Nicholls; Peter Barlis; Nick E J West; Armin Arbab-Zadeh; Jong Chul Ye; Jouke Dijkstra; Hang Lee; Jagat Narula; Filippo Crea; Sunao Nakamura; Tsunekazu Kakuta; James Fujimoto; Valentin Fuster; Ik-Kyung Jang
Journal:  Nat Rev Cardiol       Date:  2022-04-21       Impact factor: 49.421

6.  A case report of Kounis syndrome presenting with a rash, very late stent thrombosis and coronary evaginations.

Authors:  Tomohiro Fujisaki; Tomitaka Higa; Yoichi Uechi; Naoya Maehira
Journal:  Eur Heart J Case Rep       Date:  2020-02-11

7.  Clinical use of optical coherence tomography to identify angiographic silent stent thrombosis.

Authors:  Sonja E Steigen; Niels Ramsing Holm; Noreen Butt; Michael Maeng; Fumiyuki Otsuka; Renu Virmani; Elena Ladich; Terje K Steigen
Journal:  Scand Cardiovasc J       Date:  2014-06       Impact factor: 1.589

8.  Characteristics of Earlier Versus Delayed Presentation of Very Late Drug-Eluting Stent Thrombosis: An Optical Coherence Tomographic Study.

Authors:  Seung-Yul Lee; Jung-Min Ahn; Gary S Mintz; Seung-Ho Hur; So-Yeon Choi; Sang-Wook Kim; Jin Man Cho; Soon Jun Hong; Jin Won Kim; Young Joon Hong; Sang-Gon Lee; Dong-Ho Shin; Jung-Sun Kim; Byeong-Keuk Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Seung-Jung Park; Myeong-Ki Hong
Journal:  J Am Heart Assoc       Date:  2017-04-14       Impact factor: 5.501

9.  A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study.

Authors:  Anna Franzone; Serge Zaugg; Raffaele Piccolo; Maria Grazia Modena; Ghada W Mikhail; Josepa Mauri Ferré; Ruth Strasser; Liliana Grinfeld; Dik Heg; Peter Jüni; Stephan Windecker; Marie-Claude Morice
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

10.  Comparison Between Optical Frequency Domain Imaging and Intravascular Ultrasound for Percutaneous Coronary Intervention Guidance in Biolimus A9-Eluting Stent Implantation: A Randomized MISTIC-1 Non-Inferiority Trial.

Authors:  Takashi Muramatsu; Yukio Ozaki; Mamoru Nanasato; Masato Ishikawa; Ryo Nagasaka; Masaya Ohota; Yosuke Hashimoto; Yu Yoshiki; Hidemaro Takatsu; Katsuyoshi Ito; Hiroki Kamiya; Yukihiko Yoshida; Toyoaki Murohara; Hideo Izawa
Journal:  Circ Cardiovasc Interv       Date:  2020-10-27       Impact factor: 6.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.